ClinicalTrials.Veeva

Menu

Percutaneous Plug-based Arteriotomy Closure Device Use in Minimally Invasive Cardiac Surgery

K

Karolinska University Hospital

Status

Enrolling

Conditions

Minimally Invasive Cardiac Surgery

Treatments

Device: Percutaneous vascular closure

Study type

Observational

Funder types

Other

Identifiers

NCT05462769
MANTA continued

Details and patient eligibility

About

A single-center prospective study. Patients undergoing minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA; Teleflex/Essential Medical, Malvern, PA). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Enrollment

600 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Operated with minimally invasive cardiac surgery between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of percutaneous femoral cannulation with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.

Exclusion criteria

  • None.

Trial contacts and locations

1

Loading...

Central trial contact

Magnus Dalén

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems